Veterinary Medicines

FARMOLISINA, 500 mg/ ml, soluzione iniettabile per bovini, equini, suini e cani

Authorised
  • Metamizole sodium
Download as PDF

Product identification

Medicine name:
FARMOLISINA, 500 mg/ ml, soluzione iniettabile per bovini, equini, suini e cani
Active substance:
  • Metamizole sodium
Target species:
  • Cattle
  • Horse
  • Pig
  • Dog
Route of administration:
  • Intramuscular and intravenous use

Product details

Active substance and strength:
  • Metamizole sodium
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular and intravenous use
    • Cattle
      • Meat and offal
        9
        day
      • Milk
        48
        hour
    • Horse
      • Meat and offal
        16
        day
    • Pig
      • Meat and offal
        7
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetem S.p.A.
  • Ceva Sante Animale
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 101524
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 1/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."